Cyclacel Pharma (CYCC) Tops Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Net loss applicable to common shareholders: -3M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Financial Fact:
Net loss applicable to common shareholders: -3M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q2 EPS of ($0.44), $0.06 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $370 thousand versus the consensus estimate of $0 .
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HP shares slide as tech giant forecasts 2027 PC market slump
- Evercore lifts Ciena rating on AI-driven optical networking boom
- DA Davidson Reiterates Buy Rating on Vulcan Materials Company (VMC)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
